Results 11 to 20 of about 906,170 (290)
Annals of Medicine, 2021 Background There are few effective therapies for coronavirus disease 2019 (COVID-19) upon the outbreak of the pandemic. To compare the effectiveness of a novel genetically engineered recombinant super-compound interferon (rSIFN-co) with traditional ...
Chuan Li +26 more
doaj +3 more sources
CD8+ Lymphocytes from Healthy Blood Donors Secrete Antiviral Levels of Interferon-Alpha
Viruses, 2023 The adaptive immune response to viral infections features the antigen-driven expansion of CD8+ T cells. These cells are widely recognized for their cytolytic activity that is mediated through the secretion of cytokines such as perforin and granzymes ...
Fernando Teque +3 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2021 Purpose: To describe the clinical course of a patient presenting with unilateral retinopathy after perilesional interferon alpha injections for treatment of ocular surface squamous cell carcinoma.
Shiv Dalla +4 more
doaj +1 more source
Production and Characterization of Polyclonal Antibodies Against Interferon Alpha in Mice
Bioscientific Review, 2021 The polyclonal antibodies are used extensively for research purposes in many areas of biology, such as immunoprecipitation, histochemistry, enzyme linked immunosorbent assays (ELISA), diagnosis of disease and western blots. Typically, an animal’s immune
Mehreen Fatima +2 more
doaj +1 more source
Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients [PDF]
Vojnosanitetski Pregled, 2015 Background/Aim. Interaction between tumor cells and host’s immunoregulatory cells in creation of microenvironment that supports tumor progression is the focus of numerous investigations in recent years.
Stanojević Ivan +11 more
doaj +1 more source
Schwannoma response to interferon alpha
Interdisciplinary Neurosurgery, 2017 While cranial nerve schwannomas are typically benign, slow growing tumors, they are associated with morbidity both from the neuropathies and neuralgias they can produce, as well as from the treatments used to address these tumors, typically surgery or ...
Jennifer Novak +2 more
doaj +1 more source
Frontiers in Neurology, 2018 This review article provides a general perspective of the experimental and clinical work surrounding the role of type-I, type-II, and type-III interferons (IFNs) in the pathophysiology of brain and spinal cord injury. Since IFNs are themselves well-known
Francesco Roselli +4 more
doaj +1 more source
Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
Oman Journal of Ophthalmology, 2022 Ocular surface squamous neoplasia (OSSN) is the most common nonpigmented ocular surface neoplasm. Interferon-alpha (IFNα)-2b has been proved to be an effective immunotherapeutic agent to treat OSSN.
Murtuza Nuruddin +2 more
doaj +1 more source
Transcriptional responses of tumor cell lines to interferon-alpha [PDF]
, 2013 Interferon is an antiviral and antiproliferative cytokine therapeutically applied to treat hepatitis infection and cancer expansion. The beneficial effects of interferon-alpha are dependent on efficient signaling by activation of defined JAK-STAT pathway
Siegrist, Fredy
core +1 more source
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C [PDF]
, 2000 Background/Aims: Combination therapy with interferon-alpha (IFN-alpha) plus ribavirin is more efficacious than IFN-alpha monotherapy in previously untreated patients with chronic hepatitis C and patients with IFN-alpha relapse.
Leifeld, Ludger +8 more
core +1 more source